Jpmorgan Chase & CO Meridian Bioscience Inc Transaction History

Jpmorgan Chase & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$31.15 - $33.39 $5.63 Million - $6.04 Million	180,797 Added 89.91%	381,880 $12.7 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $33.55 $3.12 Million - $3.39 Million	101,051 Added 101.02%	201,083 $6.34 Million
Q2 2022 Aug 11, 2022	SELL	$23.75 - $31.69 $1.34 Million - $1.79 Million	-56,599 Reduced 36.14%	100,032 $3.04 Million
Q1 2022 May 11, 2022	BUY	$19.97 - $26.94 $434,886 - $586,672	21,777 Added 16.15%	156,631 $4.07 Million
Q4 2021 Feb 10, 2022	SELL	$17.46 - $21.61 $594,425 - $735,712	-34,045 Reduced 20.16%	134,854 $2.75 Million
Q3 2021 Nov 12, 2021	BUY	$17.35 - $22.5 $2.93 Million - $3.8 Million	168,899 New	168,899 $3.25 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.